BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918-928. [PMID: 22362002 DOI: 10.1002/bjs.8702] [Cited by in Crossref: 353] [Cited by in F6Publishing: 304] [Article Influence: 39.2] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Rehman AU, Zuo C, Sheehan CE, Lee EC, Lin J, Zhao Z, Choi E, Lee H. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators. Cancer Med 2016;5:1510-8. [PMID: 27165693 DOI: 10.1002/cam4.740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
2 Koëter T, Stijns RCH, van Koeverden S, Hugen N, van der Heijden JAG, Nederend J, van Zwam PH, Nagtegaal ID, Verheij M, Rutten HJT, de Wilt JHW. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy. Colorectal Dis 2021. [PMID: 34051043 DOI: 10.1111/codi.15760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 You K, Huang R, Zhang L, Ding P, Xiao W, Qiu B, Chang H, Zeng Z, Pan Z, Gao Y. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response. J Cancer Res Clin Oncol 2015;141:719-28. [DOI: 10.1007/s00432-014-1843-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
4 Gambacorta MA, Masciocchi C, Chiloiro G, Meldolesi E, Macchia G, van Soest J, Peters F, Collette L, Gérard JP, Ngan S, Rödel CC, Damiani A, Dekker A, Valentini V. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol 2021;154:154-60. [PMID: 32966845 DOI: 10.1016/j.radonc.2020.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Morais M, Pinto DM, Machado JC, Carneiro S. ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review. Eur J Surg Oncol 2021:S0748-7983(21)00723-X. [PMID: 34511270 DOI: 10.1016/j.ejso.2021.08.034] [Reference Citation Analysis]
6 Thies S, Langer R. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment. Front Oncol. 2013;3:262. [PMID: 24109590 DOI: 10.3389/fonc.2013.00262] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
7 Bhoday J, Glimelius B, Tait D, Glynne-Jones R, Adams R, Brown G. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on? Colorectal Dis 2018;20 Suppl 1:97-9. [PMID: 29878687 DOI: 10.1111/codi.14088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 McCoy MJ, Hemmings C, Anyaegbu CC, Austin SJ, Lee-Pullen TF, Miller TJ, Bulsara MK, Zeps N, Nowak AK, Lake RA, Platell CF. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response. Oncotarget 2017;8:19803-13. [PMID: 28177891 DOI: 10.18632/oncotarget.15048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jones HJS, Goodbrand S, Hompes R, Mortensen N, Cunningham C. Radiotherapy after local excision of rectal cancer may offer reduced local recurrence rates. Colorectal Dis 2019;21:451-9. [DOI: 10.1111/codi.14546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sun Y, Chi P, Lin H, Lu X, Huang Y, Xu Z, Huang S, Wang X. A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies. Oncotarget 2017;8:67732-43. [PMID: 28978067 DOI: 10.18632/oncotarget.18821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
11 Glynne-jones R. Watch and wait in rectal cancer: is it time to subclassify cT3? The Lancet Gastroenterology & Hepatology 2018;3:814-5. [DOI: 10.1016/s2468-1253(18)30309-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Torres-mesa PA, Oliveros R, Mesa J, Olaya N, Sánchez R. Desenlaces del manejo no quirúrgico posterior a neoadyuvancia del cáncer localmente avanzado de recto. Revista Colombiana de Cancerología 2014;18:109-19. [DOI: 10.1016/j.rccan.2014.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Healey Bird BRJ. Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit. Br J Surg 2020;107:1705-7. [PMID: 33104240 DOI: 10.1002/bjs.12014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
14 Squire T, Buchanan G, Rangiah D, Davis I, Yip D, Chua YJ, Rich T, Elsaleh H. Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer? Chronobiol Int 2017;34:492-503. [PMID: 28353363 DOI: 10.1080/07420528.2017.1301462] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
15 Xiao L, Yu X, Zhang R, Chang H, Xi S, Xiao W, Zeng Z, Zhang H, Xu R, Gao Y. Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer? Oncotarget 2016;7:34149-57. [PMID: 27167201 DOI: 10.18632/oncotarget.9178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ren DL, Li J, Yu HC, Peng SY, Lin WD, Wang XL, Ghoorun RA, Luo YX. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol 2019; 25(1): 118-137 [PMID: 30643363 DOI: 10.3748/wjg.v25.i1.118] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
17 Chetty R, McCarthy AJ. Neoadjuvant chemoradiation and rectal cancer. J Clin Pathol 2019;72:97-101. [PMID: 30593459 DOI: 10.1136/jclinpath-2018-205592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zeng WG, Liang JW, Wang Z, Zhang XM, Hu JJ, Hou HR, Zhou HT, Zhou ZX. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Chin J Cancer 2015;34:468-74. [PMID: 26268466 DOI: 10.1186/s40880-015-0033-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
19 PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg. 2018;105:650-657. [PMID: 29529336 DOI: 10.1002/bjs.10734] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 16.3] [Reference Citation Analysis]
20 Lim SG, Kim YB, Oh SY. Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer. World J Surg 2016;40:3029-34. [PMID: 27464916 DOI: 10.1007/s00268-016-3661-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Yoon HI, Koom WS, Kim YB, Min BS, Lee KY, Kim NK, Shin SJ, Ahn JB, Keum KC. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers. J Cancer Res Clin Oncol 2014;140:399-409. [DOI: 10.1007/s00432-013-1578-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Chen Q, Mao R, Zhao J, Bi X, Li Z, Huang Z, Zhang Y, Zhou J, Zhao H, Cai J. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing? Cancer Med 2020;9:7849-62. [PMID: 32886456 DOI: 10.1002/cam4.3283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hupkens BJP, Breukink SO, Stoot JHMB, Toebes RE, van der Sande ME, Melenhorst J, Beets GL, Dirksen CD. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment. Dis Colon Rectum 2020;63:598-605. [PMID: 32032202 DOI: 10.1097/DCR.0000000000001594] [Reference Citation Analysis]
24 Patel A, Spychalski P, Corrao G, Jereczek-Fossa BA, Glynne-Jones R, Garcia-Aguilar J, Kobiela J. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Acta Oncol 2021;:1-9. [PMID: 34308767 DOI: 10.1080/0284186X.2021.1953137] [Reference Citation Analysis]
25 Kennelly RP, Rogers AC, Winter DC. Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer. British Journal of Surgery 2013;100:160-6. [DOI: 10.1002/bjs.9001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
26 Hammarström K, Imam I, Mezheyeuski A, Ekström J, Sjöblom T, Glimelius B. A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer. Cancers (Basel) 2020;13:E16. [PMID: 33375133 DOI: 10.3390/cancers13010016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Pai VD, De Souza A, Patil P, Engineer R, Arya S, Saklani A. Intersphincteric resection and hand-sewn coloanal anastomosis for low rectal cancer: Short-term outcomes in the Indian setting. Indian J Gastroenterol 2015;34:23-8. [PMID: 25583650 DOI: 10.1007/s12664-014-0522-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Solanki AA, Chang DT, Liauw SL. Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. Onco Targets Ther. 2013;6:1097-1110. [PMID: 23983475 DOI: 10.2147/ott.s34869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Hearn N, Bugg W, Chan A, Vignarajah D, Cahill K, Atwell D, Lagopoulos J, Min M. Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI. Br J Radiol 2020;93:20200543. [PMID: 32877210 DOI: 10.1259/bjr.20200543] [Reference Citation Analysis]
30 Chou CL, Chen TJ, Tian YF, Chan TC, Yeh CF, Li WS, Tsai HH, Li CF, Lai HY. CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT. Life (Basel) 2021;11:646. [PMID: 34357018 DOI: 10.3390/life11070646] [Reference Citation Analysis]
31 Delishaj D, Fumagalli IC, Ursino S, Cristaudo A, Colangelo F, Stefanelli A, Alghisi A, De Nobili G, D’Amico R, Cocchi A, Ardizzoia A, Soatti CP. Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature. World J Clin Cases 2021; 9(30): 9077-9089 [DOI: 10.12998/wjcc.v9.i30.9077] [Reference Citation Analysis]
32 Smith FM, Rao C, Perez RO, Bujko K, Athanasiou T, Habr-gama A, Faiz O. Avoiding Radical Surgery Improves Early Survival in Elderly Patients With Rectal Cancer, Demonstrating Complete Clinical Response After Neoadjuvant Therapy: Results of a Decision-Analytic Model. Diseases of the Colon & Rectum 2015;58:159-71. [DOI: 10.1097/dcr.0000000000000281] [Cited by in Crossref: 76] [Cited by in F6Publishing: 20] [Article Influence: 12.7] [Reference Citation Analysis]
33 Arredondo J, Baixauli J, Beorlegui C, Arbea L, Rodríguez J, Sola JJ, Chopitea A, Hernández-lizoáin JL. Prognosis Factors for Recurrence in Patients With Locally Advanced Rectal Cancer Preoperatively Treated With Chemoradiotherapy and Adjuvant Chemotherapy. Diseases of the Colon & Rectum 2013;56:416-21. [DOI: 10.1097/dcr.0b013e318274d9c6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
34 Clancy C, Burke JP, Coffey JC. KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis. Surgical Oncology 2013;22:105-11. [DOI: 10.1016/j.suronc.2013.02.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
35 Heo J, Chun M, Noh OK, Oh YT, Suh KW, Park JE, Cho O. Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer. Cancer Res Treat. 2016;48:232-239. [PMID: 25779365 DOI: 10.4143/crt.2014.351] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
36 Ma B, Ren Y, Chen Y, Lian B, Jiang P, Li Y, Shang Y, Meng Q. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis. Int J Colorectal Dis 2019;34:113-21. [DOI: 10.1007/s00384-018-3181-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
37 Vendrely V, Denost Q, Amestoy F, Célérier B, Smith D, Rullier A, Rullier É. [Organ preserving strategies for rectal cancer treatment]. Cancer Radiother 2015;19:404-9. [PMID: 26278990 DOI: 10.1016/j.canrad.2015.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Yang J, Chen Q, Li J, Song Z, Cheng Y. Short-Term Clinical and Oncological Outcome of Prolonging Operation Interval After Neoadjuvant Chemoradiotherapy for Locally Advanced Middle and Low Rectal Cancer. Cancer Manag Res 2020;12:2315-25. [PMID: 32273768 DOI: 10.2147/CMAR.S245794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Xiao L, Yu X, Deng W, Feng H, Chang H, Xiao W, Zhang H, Xi S, Liu M, Zhu Y, Gao Y. Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy. Sci Rep. 2016;6:34923. [PMID: 27721486 DOI: 10.1038/srep34923] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
40 Codina Cazador A, Farres Coll R, Olivet Pujol F, Martin Grillo A, Pujadas de Palol M, Gómez Romeu N, Julia Bergkvist D, Ortiz Duran R, Diez Gómez E. [Clinical and oncological results of the pathological complete response in rectal cancer after neoadjuvant treatment]. Cir Esp 2013;91:417-23. [PMID: 23453426 DOI: 10.1016/j.ciresp.2012.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
41 Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol 2017;19:189-96. [PMID: 27271749 DOI: 10.1007/s12094-016-1522-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
42 Gonçalves-Ribeiro S, Sanz-Pamplona R, Vidal A, Sanjuan X, Guillen Díaz-Maroto N, Soriano A, Guardiola J, Albert N, Martínez-Villacampa M, López I, Santos C, Serra-Musach J, Salazar R, Capellà G, Villanueva A, Molleví DG. Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling. Ann Oncol 2017;28:2160-8. [PMID: 28911071 DOI: 10.1093/annonc/mdx293] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
43 Hamerla G, Meyer HJ, Hambsch P, Wolf U, Kuhnt T, Hoffmann KT, Surov A. Radiomics Model Based on Non-Contrast CT Shows No Predictive Power for Complete Pathological Response in Locally Advanced Rectal Cancer.Cancers (Basel). 2019;11:1680. [PMID: 31671766 DOI: 10.3390/cancers11111680] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
44 Krajnović M, Marković B, Knežević-Ušaj S, Nikolić I, Stanojević M, Nikolić V, Šiljić M, Jovanović Ćupić S, Dimitrijević B. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics. Pathol Res Pract 2016;212:598-603. [PMID: 27184911 DOI: 10.1016/j.prp.2016.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 Wolf JH, Hung YC, Cox S, Aghedo B, Mavanur A, Svoboda S, D'Adamo CR. Pathologic complete response is associated with decreased morbidity following rectal cancer resection. Am J Surg 2021;222:390-4. [PMID: 33261851 DOI: 10.1016/j.amjsurg.2020.11.050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol 2014;30:165-74. [PMID: 25210685 DOI: 10.3393/ac.2014.30.4.165] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
47 Andrade VA, Coy CS, Leal RF, Fagundes JJ, Martinez CA, Ayrizono Mde L. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response. Arq Gastroenterol 2016;53:163-8. [PMID: 27438421 DOI: 10.1590/S0004-28032016000300008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Kelley KA, Ruhl RA, Rana SR, Dewey E, Espinosa C, Thomas CR Jr, Martindale RG, Anand S, Tsikitis VL. Understanding and Resetting Radiation Sensitivity in Rectal Cancer. Ann Surg 2017;266:610-6. [PMID: 28742699 DOI: 10.1097/SLA.0000000000002409] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
49 Deantonio L, Caroli A, Puta E, Ferrante D, Apicella F, Turri L, Sacchetti G, Brambilla M, Krengli M. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Radiat Oncol 2018;13:211. [PMID: 30359275 DOI: 10.1186/s13014-018-1154-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
50 Lee KH, Song MS, Park JB, Kim JS, Kang DY, Kim JY. A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer. Ann Coloproctol 2013;29:192-7. [PMID: 24278857 DOI: 10.3393/ac.2013.29.5.192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
51 Calmels M, Collard MK, Cazelles A, Frontali A, Maggiori L, Panis Y. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case‐matched study in 110 selected high‐risk patients with rectal cancer. Colorectal Dis 2020;22:1999-2007. [DOI: 10.1111/codi.15323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Kong JC, Guerra GR, Warrier SK, Lynch AC, Michael M, Ngan SY, Phillips W, Ramsay G, Heriot AG. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis. Colorectal Dis 2018;20:574-85. [DOI: 10.1111/codi.14106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
53 Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. Clin Cancer Res 2020;26:5140-52. [PMID: 32665297 DOI: 10.1158/1078-0432.CCR-20-1695] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 31.0] [Reference Citation Analysis]
54 Taira T, Nozawa H, Kawai K, Sasaki K, Murono K, Kaneko M, Emoto S, Iida Y, Ishii H, Yokoyama Y, Anzai H, Sonoda H, Ishihara S. Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy. In Vivo 2020;34:3559-64. [PMID: 33144468 DOI: 10.21873/invivo.12199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Van den Begin R, Kleijnen JP, Engels B, Philippens M, van Asselen B, Raaymakers B, Reerink O, De Ridder M, Intven M. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI. Acta Oncol 2018;57:723-7. [PMID: 29157069 DOI: 10.1080/0284186X.2017.1400689] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
56 Bedin C, Crotti S, D'Angelo E, D'Aronco S, Pucciarelli S, Agostini M. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy. Curr Med Chem 2020;27:4274-94. [PMID: 31060482 DOI: 10.2174/0929867326666190507084839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Chou CL, Chen TJ, Tian YF, Chan TC, Yeh CF, Li WS, Tsai HH, Li CF, Lai HY. Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT. J Clin Med 2021;10:3030. [PMID: 34300195 DOI: 10.3390/jcm10143030] [Reference Citation Analysis]
58 Wang B, Huang Y. Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis. J Cancer Res Clin Oncol 2020;146:2161-71. [PMID: 32328776 DOI: 10.1007/s00432-020-03222-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Dinaux AM, Amri R, Bordeianou LG, Hong TS, Wo JY, Blaszkowsky LS, Allen JN, Murphy JE, Kunitake H, Berger DL. The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer-a Large Single-Center Experience. J Gastrointest Surg 2017;21:1153-8. [PMID: 28386670 DOI: 10.1007/s11605-017-3408-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
60 Qin CJ, Song XM, Chen ZH, Ren XQ, Xu KW, Jing H, He YL. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy. Oncotarget 2015;6:32193-204. [PMID: 26320178 DOI: 10.18632/oncotarget.4975] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
61 Du D, Su Z, Wang D, Liu W, Wei Z. Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis. Clin Colorectal Cancer. 2018;17:13-24. [PMID: 29153429 DOI: 10.1016/j.clcc.2017.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
62 Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One 2016;11:e0156910. [PMID: 27336466 DOI: 10.1371/journal.pone.0156910] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
63 Jäger T, Neureiter D, Urbas R, Klieser E, Hitzl W, Emmanuel K, Dinnewitzer A. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer. Dis Colon Rectum 2017;60:815-26. [PMID: 28682967 DOI: 10.1097/DCR.0000000000000806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
64 De Palma FDE, Luglio G, Tropeano FP, Pagano G, D'Armiento M, Kroemer G, Maiuri MC, De Palma GD. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Int J Mol Sci 2020;21:E7040. [PMID: 32987896 DOI: 10.3390/ijms21197040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
65 Glimelius B. Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? Front Oncol. 2014;4:50. [PMID: 24778990 DOI: 10.3389/fonc.2014.00050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
66 Lee SY, Kim CH, Kim YJ, Kwak HD, Ju JK, Kim HR. Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer. Ann Surg Treat Res 2019;96:116-22. [PMID: 30838183 DOI: 10.4174/astr.2019.96.3.116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Omidvari S, Hamedi SH, Mohammadianpanah M, Razzaghi S, Mosalaei A, Ahmadloo N, Ansari M, Pourahmad S. Comparison of abdominoperineal resection and low anterior resection in lower and middle rectal cancer. Journal of the Egyptian National Cancer Institute 2013;25:151-60. [DOI: 10.1016/j.jnci.2013.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
68 Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Curr Treat Options Oncol. 2017;18:13. [PMID: 28281215 DOI: 10.1007/s11864-017-0454-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
69 Ortiz H, Ciga MA, Armendariz P, Kreisler E, Codina-Cazador A, Gomez-Barbadillo J, Garcia-Granero E, Roig JV, Biondo S; Spanish Rectal Cancer Project. Multicentre propensity score-matched analysis of conventional versus extended abdominoperineal excision for low rectal cancer. Br J Surg. 2014;101:874-882. [PMID: 24817654 DOI: 10.1002/bjs.9522] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 8.6] [Reference Citation Analysis]
70 Amodeo S, Rosman AS, Desiato V, Hindman NM, Newman E, Berman R, Pachter HL, Melis M. MRI-Based Apparent Diffusion Coefficient for Predicting Pathologic Response of Rectal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018;211:W205-W216. [PMID: 30240291 DOI: 10.2214/ajr.17.19135] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
71 Jácome AA, Oliveira FA, Lino F, Lima JPSN. Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis. Clin Colorectal Cancer 2021;20:265-72. [PMID: 34158251 DOI: 10.1016/j.clcc.2021.05.006] [Reference Citation Analysis]
72 Shoji H, Motegi M, Takakusagi Y, Asao T, Kuwano H, Takahashi T, Ogoshi K. Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses. Oncol Rep 2017;37:695-704. [PMID: 27959450 DOI: 10.3892/or.2016.5300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Sloothaak DA, Geijsen DE, van Leersum NJ, Punt CJ, Buskens CJ, Bemelman WA, Tanis PJ; Dutch Surgical Colorectal Audit. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100:933-939. [PMID: 23536485 DOI: 10.1002/bjs.9112] [Cited by in Crossref: 167] [Cited by in F6Publishing: 147] [Article Influence: 20.9] [Reference Citation Analysis]
74 Mace AG, Pai RK, Stocchi L, Kalady MF. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum. 2015;58:32-44. [PMID: 25489692 DOI: 10.1097/dcr.0000000000000266] [Cited by in Crossref: 69] [Cited by in F6Publishing: 36] [Article Influence: 11.5] [Reference Citation Analysis]
75 Sposato LA, Lam Y, Karapetis C, Vatandoust S, Roy A, Hakendorf P, Dwyer A, de Fontgalland D, Hollington P, Wattchow D. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience. Asia Pac J Clin Oncol 2018;14:439-45. [PMID: 29932278 DOI: 10.1111/ajco.12993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
76 Iwamoto M, Kawada K, Hida K, Hasegawa S, Sakai Y. Delayed anastomotic leakage following laparoscopic intersphincteric resection for lower rectal cancer: report of four cases and literature review. World J Surg Oncol 2017;15:143. [PMID: 28764707 DOI: 10.1186/s12957-017-1208-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Chen YC, Tsai HL, Li CC, Huang CW, Chang TK, Su WC, Chen PJ, Yin TC, Huang CM, Wang JY. Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer. PLoS One 2021;16:e0259460. [PMID: 34727133 DOI: 10.1371/journal.pone.0259460] [Reference Citation Analysis]
78 Tan W, Luo W, Jia W, Liang G, Xie X, Zheng W, Song E, Su F, Gong C. A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer. Oncotarget 2016;7:87312-22. [PMID: 27894097 DOI: 10.18632/oncotarget.13549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
79 Demir A, Alan O, Oruc E. Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment. World J Surg Oncol 2019;17:50. [PMID: 30871581 DOI: 10.1186/s12957-019-1588-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Olsen JR, Apisarnthanarax S, Murphy JD, Tait D, Huguet F, Hallemeier CL, Jabbour SK. Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers. Int J Radiat Oncol Biol Phys 2019;105:1-10. [PMID: 31422802 DOI: 10.1016/j.ijrobp.2019.04.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Allaix ME, Arezzo A, Morino M. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review. Surg Endosc 2016;30:4841-52. [DOI: 10.1007/s00464-016-4818-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
82 Dossa F, Acuna SA, Rickles AS, Berho M, Wexner SD, Quereshy FA, Baxter NN, Chadi SA. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection. JAMA Oncol 2018;4:930-7. [PMID: 29710274 DOI: 10.1001/jamaoncol.2017.5597] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 23.5] [Reference Citation Analysis]
83 Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol 2017;19:189-96. [DOI: 10.1007/s12094-016-1522-0] [Reference Citation Analysis]
84 Detering R, Borstlap WAA, Broeders L, Hermus L, Marijnen CAM, Beets-Tan RGH, Bemelman WA, van Westreenen HL, Tanis PJ; Dutch Snapshot Research Group. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes. Ann Surg Oncol. 2019;26:437-448. [PMID: 30547330 DOI: 10.1245/s10434-018-07097-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
85 Kılıç D, Sert F, Görken İB, Arıcan Alıcıkuş Z, Aktürk N, Kaytan Sağlam E, Kizir A, Özkök S, Yılmaz HT, Göçen F, Yalman D. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD). Turk J Gastroenterol 2020;31:368-77. [PMID: 32519956 DOI: 10.5152/tjg.2020.19225] [Reference Citation Analysis]
86 Pereira MA, Dias AR, Faraj SF, Nahas CSR, Imperiale AR, Marques CFS, Cotti GC, Azevedo BC, Nahas SC, de Mello ES, Ribeiro U. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer. Tech Coloproctol 2017;21:745-54. [DOI: 10.1007/s10151-017-1670-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Sclafani F, Brown G. Extramural Venous Invasion (EMVI) and Tumour Regression Grading (TRG) as Potential Prognostic Factors for Risk Stratification and Treatment Decision in Rectal Cancer. Curr Colorectal Cancer Rep 2016;12:130-40. [DOI: 10.1007/s11888-016-0319-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
88 Probst CP, Becerra AZ, Aquina CT, Tejani MA, Wexner SD, Garcia-Aguilar J, Remzi FH, Dietz DW, Monson JR, Fleming FJ; Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh). Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. J Am Coll Surg. 2015;221:430-440. [PMID: 26206642 DOI: 10.1016/j.jamcollsurg.2015.04.010] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 15.2] [Reference Citation Analysis]
89 Lutsyk M, Awawda M, Gourevich K, Ben Yosef R. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. Am J Clin Oncol 2021;44:482-6. [PMID: 34269693 DOI: 10.1097/COC.0000000000000846] [Reference Citation Analysis]
90 Peng H, You K, Zhang R, Xi S, Zhang T, Dong J, Cai M, Wang C, Zhang H, Zhou T, Gao Y, Wen B. Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma. Oncotarget 2016;7:35233-40. [PMID: 27153549 DOI: 10.18632/oncotarget.9125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
91 Kuan F, Lai C, Ku H, Wu C, Hsieh M, Liu T, Yeh C, Lee K. The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation: Delayed surgery and adjuvant chemotherapy on rectal cancer. Int J Cancer 2017;140:1662-9. [DOI: 10.1002/ijc.30562] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
92 Golo D, But-Hadzic J, Anderluh F, Brecelj E, Edhemovic I, Jeromen A, Omejc M, Oblak I, Secerov-Ermenc A, Velenik V. Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial. Radiol Oncol. 2018;52:267-274. [PMID: 30210040 DOI: 10.2478/raon-2018-0028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
93 Xynos E, Tekkis P, Gouvas N, Vini L, Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Triantopoulou C, Xynogalos S, Karachaliou N, Ziras N, Zoras O, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)]. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:103-26. [PMID: 27064746 DOI: 10.20524/aog.2016.0003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Li N, Dou L, Zhang Y, Jin J, Wang G, Xiao Q, Li Y, Wang X, Ren H, Fang H, Wang W, Wang S, Liu Y, Song Y. Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer. Gastrointest Endosc 2017;85:669-74. [PMID: 27354104 DOI: 10.1016/j.gie.2016.06.042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Letaief F, Nasri M, Ayadi M, Meddeb K, Mokrani A, Yahyaoui Y, Chraiet N, Raies H, Mezlini A. Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience. Cancer Biol Med 2017;14:327-34. [PMID: 28884049 DOI: 10.20892/j.issn.2095-3941.2017.0037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Couch DG, Hemingway DM. Complete radiotherapy response in rectal cancer: A review of the evidence. World J Gastroenterol 2016; 22(2): 467-470 [PMID: 26811600 DOI: 10.3748/wjg.v22.i2.467] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
97 Brown PJ, Rossington H, Taylor J, Lambregts DMJ, Morris E, West NP, Quirke P, Tolan D; YCR BCIP Study Group. Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice. Eur Radiol 2019;29:5121-8. [PMID: 30796574 DOI: 10.1007/s00330-019-06028-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
98 Asoglu O, Tokmak H, Bakir B, Demir G, Ozyar E, Atalar B, Goksel S, Koza B, Guven Mert A, Demir A, Guven K. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases. Eur J Surg Oncol 2020;46:402-9. [PMID: 31955995 DOI: 10.1016/j.ejso.2019.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Santos MD, Silva C, Rocha A, Nogueira C, Matos E, Lopes C. Predictive Response Value of Pre- and Postchemoradiotherapy Variables in Rectal Cancer: An Analysis of Histological Data. Patholog Res Int 2016;2016:2164609. [PMID: 26885438 DOI: 10.1155/2016/2164609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
100 Franke AJ, Parekh H, Starr JS, Tan SA, Iqbal A, George TJ. Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management. Clinical Colorectal Cancer 2018;17:1-12. [DOI: 10.1016/j.clcc.2017.06.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
101 Yu J, Li N, Wang X, Ren H, Wang W, Wang S, Song Y, Liu Y, Li Y, Zhou X, Luo A, Liu Z, Jin J. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. Oncotarget. 2016;7:64233-64243. [PMID: 27572313 DOI: 10.18632/oncotarget.11649] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
102 Hu H, Huang J, Lan P, Wang L, Huang M, Wang J, Deng Y. CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial. BMC Cancer. 2018;18:1145. [PMID: 30458734 DOI: 10.1186/s12885-018-4997-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
103 Kammar P, Chaturvedi A, Sivasanker M, de'Souza A, Engineer R, Ostwal V, Saklani A. Impact of delaying surgery after chemoradiation in rectal cancer: outcomes from a tertiary cancer centre in India. J Gastrointest Oncol 2020;11:13-22. [PMID: 32175101 DOI: 10.21037/jgo.2019.12.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
104 Garland ML, Vather R, Bunkley N, Pearse M, Bissett IP. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2014;29:301-307. [PMID: 24420737 DOI: 10.1007/s00384-013-1821-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 9.7] [Reference Citation Analysis]
105 Bowden DL, Sutton PA, Wall MA, Jithesh PV, Jenkins RE, Palmer DH, Goldring CE, Parsons JL, Park BK, Kitteringham NR, Vimalachandran D. Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response. J Proteomics 2018;179:53-60. [PMID: 29518574 DOI: 10.1016/j.jprot.2018.02.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
106 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Pucciarelli S, Giandomenico F, De Paoli A, Gavaruzzi T, Lotto L, Mantello G, Barba C, Zotti P, Flora S, Del Bianco P. Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br J Surg 2017;104:138-47. [PMID: 27706805 DOI: 10.1002/bjs.10318] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
108 Dinaux A, Leijssen L, Bordeianou L, Kunitake H, Amri R, Berger D. The negative impact of understaging rectal cancer patients. The American Journal of Surgery 2018;216:93-8. [DOI: 10.1016/j.amjsurg.2017.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Huang CM, Huang MY, Ma CJ, Yeh Y-, Tsai HL, Huang CW, Huang CJ, Wang JY. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer. Radiat Oncol. 2017;12:48. [PMID: 28270172 DOI: 10.1186/s13014-017-0790-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
110 Lee YC, Hsieh CC, Chuang JP. Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis. Dis Colon Rectum. 2013;56:1093-1101. [PMID: 23929020 DOI: 10.1097/dcr.0b013e318298e36b] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
111 Westerhoff M, Osecky M, Langer R. Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey. Mod Pathol 2020;33:676-89. [PMID: 31673084 DOI: 10.1038/s41379-019-0393-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
112 Zhai Z, Zhang K, Wang C, Zhang T, Wang L, Yao J, Wang Z. Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer. Curr Oncol 2021;28:283-93. [PMID: 33419188 DOI: 10.3390/curroncol28010033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Souadka A, Majbar MA, Benkabbou A, Serji B, Souiki T, Bouchentouf SM, Abid M, El Khannousi B, El Harroudi T, El Malki HO, Raiss M, Ifrine L, Mazaz K, Zentar A, Mohsine R, Souadka A, Belkouchi A, Ahallat M, Hrora A; Moroccan Society of Surgery. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series. BMC Cancer 2019;19:1008. [PMID: 31660903 DOI: 10.1186/s12885-019-6239-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Li YH, Li JL, Zhu XG, He JY, Lin LM, Lin XY, Tang LR, Cai Y. Associations of tumor regression grade with outcomes in patients with locally advanced rectal cancer treated with preoperative two-week course of radiotherapy. Oncotarget 2017;8:100165-75. [PMID: 29245968 DOI: 10.18632/oncotarget.22118] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 McCoy MJ, Hemmings C, Miller TJ, Austin SJ, Bulsara MK, Zeps N, Nowak AK, Lake RA, Platell CF. Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer. Br J Cancer 2015;113:1677-86. [PMID: 26645238 DOI: 10.1038/bjc.2015.427] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
116 Wang XJ, Zheng ZR, Chi P, Lin HM, Lu XR, Huang Y. Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2016;2016:6756859. [PMID: 27190505 DOI: 10.1155/2016/6756859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
117 Zaborowski AM, Winter DC, Lynch L. The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review. Br J Cancer 2021. [PMID: 34302062 DOI: 10.1038/s41416-021-01475-x] [Reference Citation Analysis]
118 Cui CL, Luo WY, Cosman BC, Eisenstein S, Simpson D, Ramamoorthy S, Murphy J, Lopez N. Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation. Ann Surg Oncol 2021. [PMID: 34529175 DOI: 10.1245/s10434-021-10576-z] [Reference Citation Analysis]
119 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
120 Kwak Y, Kim K, Lee JH, Kim SH, Cho HM, Kim DY, Kim TH, Kim SY, Baek JY, Oh JH, Nam TK, Yoon MS, Jeong JU, Chie EK, Jang HS, Kim JS. Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer. Radiotherapy and Oncology 2016;119:512-8. [DOI: 10.1016/j.radonc.2016.03.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
121 Du B, Wang X, Wu D, Wang T, Yang X, Wang J, Shi X, Chen L, Zhang W. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer. Mol Med Rep 2018;18:1909-16. [PMID: 29956755 DOI: 10.3892/mmr.2018.9215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
122 Mccoy MJ, Hemmings C, Hillery S, Penter C, Bulsara MK, Zeps N, Platell CF. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?: Tumour regression and rectal cancer prognosis. ANZ J Surg 2017;87:E233-9. [DOI: 10.1111/ans.13394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
123 Martellucci J, Alemanno G, Castiglione F, Bergamini C, Valeri A. Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer. Updates Surg 2015;67:47-53. [PMID: 25702261 DOI: 10.1007/s13304-015-0281-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
124 Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC. Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol. 2013;20:2929-2936. [PMID: 23666095 DOI: 10.1245/s10434-013-2967-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]
125 Morino M, Allaix ME. Transanal endoscopic microsurgery: what indications in 2013? Gastroenterol Rep (Oxf). 2013;1:75-84. [PMID: 24759812 DOI: 10.1093/gastro/got012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
126 Prall F, Schmitt O, Schiffmann L. Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study. World J Surg Oncol 2015;13:155. [PMID: 25896880 DOI: 10.1186/s12957-015-0572-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
127 Qin C, Ren X, Xu K, Chen Z, He Y, Song X. Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials. Gastroenterol Res Pract 2014;2014:910956. [PMID: 25477955 DOI: 10.1155/2014/910956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
128 De Felice F, Izzo L, Musio D, Magnante AL, Bulzonetti N, Pugliese F, Izzo P, Di Cello P, Lucchetti P, Izzo S, Tombolini V. Clinical predictive factors of pathologic complete response in locally advanced rectal cancer. Oncotarget 2016;7:33374-80. [PMID: 26992214 DOI: 10.18632/oncotarget.8133] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
129 Glynne-Jones R, Carvalho C. Drug Combinations in Preoperative Chemoradiation for Rectal Cancer. Semin Radiat Oncol 2016;26:211-9. [PMID: 27238473 DOI: 10.1016/j.semradonc.2016.02.002] [Reference Citation Analysis]
130 Rizzo G, Zaccone G, Magnocavallo M, Mattana C, Pafundi DP, Gambacorta MA, Valentini V, Coco C. Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. Eur J Surg Oncol 2017;43:1488-93. [PMID: 28583790 DOI: 10.1016/j.ejso.2017.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
131 Lorenzon L, Parini D, Rega D, Mellano A, Vigorita V, Biondi A, Jaminez-Rosellon R, Scheiterle M, Giannini I, Gallo G, Marino G, Turati L, Marsanic P, De Franco L, Marano L, De Luca R; Senior SICO Supervising Members(1). Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO). Eur J Surg Oncol 2017;43:1472-80. [PMID: 28571778 DOI: 10.1016/j.ejso.2017.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
132 Takenami T, Tsujinaka S, Takahashi J, Tamaki S, Maemoto R, Fukuda R, Ishikawa H, Kakizawa N, Hasegawa F, Kikugawa R, Miyakura Y, Suzuki K, Tanaka A, Rikiyama T. Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases. Case Rep Surg 2019;2019:8129358. [PMID: 31049241 DOI: 10.1155/2019/8129358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Chiloiro G, Meldolesi E, Giraffa M, Capocchiano ND, Barbaro B, Coco C, Corvari B, De Franco P, D'Ugo D, Alfieri S, Manfredi R, Valentini V, Gambacorta MA. Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis. Clin Transl Radiat Oncol 2021;28:1-9. [PMID: 33732909 DOI: 10.1016/j.ctro.2021.02.009] [Reference Citation Analysis]
134 Chen H, Shi L, Nguyen KNB, Monjazeb AM, Matsukuma KE, Loehfelm TW, Huang H, Qiu J, Rong Y. MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation. Adv Radiat Oncol 2020;5:1286-95. [PMID: 33305090 DOI: 10.1016/j.adro.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 van der Sluis FJ, Couwenberg AM, de Bock GH, Intven MPW, Reerink O, van Leeuwen BL, van Westreenen HL. Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer. British Journal of Surgery 2020;107:131-9. [DOI: 10.1002/bjs.11324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
136 Hiyoshi Y, Akiyoshi T, Inoue R, Murofushi K, Yamamoto N, Fukunaga Y, Ueno M, Baba H, Mori S, Yamaguchi T. Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Oncotarget. 2017;8:79201-79211. [PMID: 29108299 DOI: 10.18632/oncotarget.16760] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
137 Simpson G, Hopley P, Wilson J, Day N, Haworth A, Montazeri A, Smith D, Titu L, Anderson J, Agbamu D, Walsh C. Long-term outcomes of real world 'watch and wait' data for rectal cancer after neoadjuvant chemoradiotherapy. Colorectal Dis 2020;22:1568-76. [PMID: 32686268 DOI: 10.1111/codi.15177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
138 Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 2012;99:1211-8. [PMID: 22864880 DOI: 10.1002/bjs.8821] [Cited by in Crossref: 192] [Cited by in F6Publishing: 151] [Article Influence: 21.3] [Reference Citation Analysis]
139 Liu Y, Zhang KC, Huang XH, Xi HQ, Gao YH, Liang WQ, Wang XX, Chen L. Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes. World J Gastroenterol 2018; 24(2): 257-265 [PMID: 29375211 DOI: 10.3748/wjg.v24.i2.257] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
140 Zhang C, Ye F, Liu Y, Ouyang H, Zhao X, Zhang H. Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Oncotarget 2018;9:4862-74. [PMID: 29435147 DOI: 10.18632/oncotarget.23419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
141 van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol. 2013;24:1762-1769. [PMID: 23524865 DOI: 10.1093/annonc/mdt124] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
142 Sun W, Li G, Wan J, Zhu J, Shen W, Zhang Z. Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy. Oncotarget 2016;7:69507-17. [PMID: 27486758 DOI: 10.18632/oncotarget.10875] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
143 Liao YT, Lin YL, Huang J, Hung JS, Lin BR. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study. Int J Colorectal Dis 2021;36:509-16. [PMID: 33128083 DOI: 10.1007/s00384-020-03787-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
144 Babar L, Bakalov V, Abel S, Ashraf O, Finley GG, Raj MS, Lundeen K, Monga DK, Kirichenko AV, Wegner RE. Retrospective review of total neoadjuvant therapy. World J Gastrointest Oncol 2019; 11(10): 857-865 [PMID: 31662824 DOI: 10.4251/wjgo.v11.i10.857] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Ryan JE, Warrier SK, Lynch AC, Ramsay RG, Phillips WA, Heriot AG. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis 2016;18:234-46. [DOI: 10.1111/codi.13207] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 13.2] [Reference Citation Analysis]
146 Peng HH, You KY, Wang CT, Huang R, Shan HB, Zhou JH, Pei XQ, Gao YH, Wen BX, Liu MZ. Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Gastroenterol Rep (Oxf) 2013;1:186-92. [PMID: 24759964 DOI: 10.1093/gastro/got028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
147 Rodríguez-Fraile M, Cózar-Santiago MP, Sabaté-Llobera A, Caresia-Aróztegui AP, Delgado Bolton RC, Orcajo-Rincon J, de Arcocha-Torres M, García-Velloso MJ, García-Talavera P. FDG PET/CT in colorectal cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2020;39:57-66. [PMID: 31776063 DOI: 10.1016/j.remn.2019.09.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
148 Gash KJ, Chambers AC, Cotton DE, Williams AC, Thomas MG. Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy. Br J Cancer 2017;117:210-9. [PMID: 28641310 DOI: 10.1038/bjc.2017.175] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
149 Zhang Q, Liang J, Chen J, Mei S, Wang Z. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Asian Pac J Cancer Prev 2021;22:1607-11. [PMID: 34048192 DOI: 10.31557/APJCP.2021.22.5.1607] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Motoi F, Unno M. Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol? Ann Gastroenterol Surg 2020;4:100-8. [PMID: 32258974 DOI: 10.1002/ags3.12311] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
151 田含含, 王海峰, 张瑾熔, 阿衣古丽·哈热, 伊斯刊达尔·阿布力米提. 术前放化疗与手术时间间隔对ⅢA、ⅢB期直肠癌的影响. 世界华人消化杂志 2014; 22(26): 3918-3924 [DOI: 10.11569/wcjd.v22.i26.3918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Espín E, Ciga MA, Pera M, Ortiz H; Spanish Rectal Cancer Project. Oncological outcome following anastomotic leak in rectal surgery. Br J Surg 2015;102:416-22. [PMID: 25619499 DOI: 10.1002/bjs.9748] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
153 Wu H, Fang C, Huang L, Fan C, Wang C, Yang L, Li Y, Zhou Z. Short-course radiotherapy with immediate or delayed surgery in rectal cancer: A meta-analysis. Int J Surg 2018;56:195-202. [PMID: 29807169 DOI: 10.1016/j.ijsu.2018.05.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
154 Langer R, Becker K. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. Virchows Arch 2018;472:175-86. [PMID: 28918544 DOI: 10.1007/s00428-017-2232-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
155 Greenbaum A, Martin DR, Bocklage T, Lee JH, Ness SA, Rajput A. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Clin Colorectal Cancer 2019;18:102-9. [PMID: 30935775 DOI: 10.1016/j.clcc.2019.02.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
156 Manceau G, Margot N, Augustin J, Bardier A, Simon J, Bachet J, Spano J, Maingon P, Vaillant J, Karoui M. YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence. Digestive and Liver Disease 2020;52:214-20. [DOI: 10.1016/j.dld.2019.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Rao C, Smith F, Martin A, Dhadda A, Stewart A, Gollins S, Collins B, Athanasiou T, Sun Myint A. A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy. Clinical Oncology 2018;30:166-77. [DOI: 10.1016/j.clon.2017.11.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Koo PJ, Kim S, Chang S, Kwak JJ. Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer. Clinical Colorectal Cancer 2016;15:e213-9. [DOI: 10.1016/j.clcc.2016.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
159 Fiore M, Greco C, Coppola A, Caricato M, Caputo D, Trecca P, Floreno B, Rinaldi CG, Ippolito E, Capolupo GT, Grippo R, Beomonte Zobel B, D'Angelillo RM, Trodella L, Ramella S. Long-Term Results of a Prospective Phase 2 Study on Volume De-Escalation in Neoadjuvant Chemoradiotherapy of Rectal Cancer. Pract Radiat Oncol 2021;11:e186-94. [PMID: 33002647 DOI: 10.1016/j.prro.2020.09.009] [Reference Citation Analysis]
160 Lartigau C, Lebreton G, Alves A. Local resection for small rectal cancer. J Visc Surg. 2013;150:325-331. [PMID: 24016715 DOI: 10.1016/j.jviscsurg.2013.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
161 Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC. Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy. Ann Surg. 2014;259:723-727. [PMID: 23744576 DOI: 10.1097/sla.0b013e31828f6c91] [Cited by in Crossref: 66] [Cited by in F6Publishing: 24] [Article Influence: 9.4] [Reference Citation Analysis]
162 Chee CG, Kim YH, Lee KH, Lee YJ, Park JH, Lee HS, Ahn S, Kim B. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis. PLoS One. 2017;12:e0182883. [PMID: 28797063 DOI: 10.1371/journal.pone.0182883] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
163 Zhang X, Fan J, Zhang L, Wang J, Wang M, Zhu J. Association Between Three-Dimensional Transrectal Ultrasound Findings and Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: An Observational Study. Front Oncol 2021;11:648839. [PMID: 34178635 DOI: 10.3389/fonc.2021.648839] [Reference Citation Analysis]
164 Elmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol 2013;68:e524-31. [PMID: 23830776 DOI: 10.1016/j.crad.2013.05.094] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
165 Tong T, Sun Y, Gollub MJ, Peng W, Cai S, Zhang Z, Gu Y. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging. 2015;42:673-680. [PMID: 25652254 DOI: 10.1002/jmri.24835] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 8.7] [Reference Citation Analysis]
166 Zaborowski AM, Stakelum A, Winter DC. Anastomotic leak risk in complete responders to neoadjuvant therapy for rectal cancer: a systematic review. Int J Colorectal Dis 2021;36:671-6. [PMID: 33427960 DOI: 10.1007/s00384-021-03833-w] [Reference Citation Analysis]
167 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Minamiya Y. Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer. Ann Surg Oncol 2021;28:2101-10. [PMID: 33051740 DOI: 10.1245/s10434-020-09206-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Torok JA, Palta M, Willett CG, Czito BG. Nonoperative management of rectal cancer: NOM of Rectal Cancer. Cancer 2016;122:34-41. [DOI: 10.1002/cncr.29735] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
169 Liu L, Cao C, Zhu Y, Li D, Feng H, Luo J, Tang Z, Liu P, Lu K, Ju H, Zhang N. Preoperative chemoradiotherapy with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer: long-term results of a phase II trial. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0512-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
170 Hayes IP, Milanzi E, Gibbs P, Reece JC. Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum. Ann Surg Oncol 2020;27:1570-9. [PMID: 31773520 DOI: 10.1245/s10434-019-08105-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
171 Akiyoshi T, Tanaka N, Kiyotani K, Gotoh O, Yamamoto N, Oba K, Fukunaga Y, Ueno M, Mori S. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer. Br J Surg. 2019;106:1381-1392. [PMID: 31197828 DOI: 10.1002/bjs.11179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
172 Yeom SS, Lee SY, Kim CH, Kim YJ, Nam TK, Kim HR. Non-operative treatment outcome for rectal cancer patient with clinical complete response after neoadjuvant chemoradiotherapy. Asian J Surg 2019;42:823-31. [PMID: 30956039 DOI: 10.1016/j.asjsur.2018.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
173 Creavin B, Ryan E, Martin ST, Hanly A, O'Connell PR, Sheahan K, Winter DC. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116:169-174. [PMID: 27997526 DOI: 10.1038/bjc.2016.417] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
174 Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther 2021;21:193-203. [PMID: 33161803 DOI: 10.1080/14737140.2021.1845145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Passardi A, Rapposelli IG, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Avanzolini A, Cavaliere D, Rudnas B, Valgiusti M, Barone D, Ferroni F, Frassineti GL, Romeo A. Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial. Ther Adv Med Oncol 2020;12:1758835920977139. [PMID: 33343722 DOI: 10.1177/1758835920977139] [Reference Citation Analysis]
176 Thavaneswaran S, Price TJ. Optimal therapy for resectable rectal cancer. Expert Rev Anticancer Ther 2016;16:285-302. [PMID: 26652907 DOI: 10.1586/14737140.2016.1130627] [Reference Citation Analysis]
177 Ryan JE, Warrier SK, Lynch AC, Heriot AG. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis. 2015;17:849-861. [PMID: 26260213 DOI: 10.1111/codi.13081] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
178 Damin DC, Lazzaron AR. Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol 2014; 20(4): 877-887 [PMID: 24574762 DOI: 10.3748/wjg.v20.i4.877] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
179 Smart CJ, Cunningham C, Bach SP. Transanal endoscopic microsurgery. Best Pract Res Clin Gastroenterol. 2014;28:143-157. [PMID: 24485262 DOI: 10.1016/j.bpg.2013.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
180 Li Z, Ma X, Shen F, Lu H, Xia Y, Lu J. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models. BMC Med Imaging 2021;21:30. [PMID: 33593304 DOI: 10.1186/s12880-021-00560-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
181 Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center. ISRN Surg. 2014;2014:310542. [PMID: 24729903 DOI: 10.1155/2014/310542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
182 Zhu J, Zeng W, Ge L, Yang X, Wang Q, Wang H. Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis. Medicine (Baltimore) 2019;98:e15241. [PMID: 31027072 DOI: 10.1097/MD.0000000000015241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
183 Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Mod Pathol 2021. [PMID: 34611303 DOI: 10.1038/s41379-021-00919-2] [Reference Citation Analysis]
184 Lovinfosse P, Polus M, Van Daele D, Martinive P, Daenen F, Hatt M, Visvikis D, Koopmansch B, Lambert F, Coimbra C, Seidel L, Albert A, Delvenne P, Hustinx R. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2018;45:365-375. [PMID: 29046927 DOI: 10.1007/s00259-017-3855-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 16.8] [Reference Citation Analysis]
185 Kripp M, Horisberger K, Mai S, Kienle P, Gaiser T, Post S, Wenz F, Merx K, Hofheinz RD. Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials. Gastroenterol Res Pract 2015;2015:273489. [PMID: 25861256 DOI: 10.1155/2015/273489] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
186 Kawai K, Ishihara S, Nozawa H, Hata K, Kiyomatsu T, Morikawa T, Fukayama M, Watanabe T. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer. Dis Colon Rectum. 2017;60:368-375. [PMID: 28267003 DOI: 10.1097/dcr.0000000000000742] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
187 Rubinkiewicz M, Zarzycki P, Czerwińska A, Wysocki M, Gajewska N, Torbicz G, Budzyński A, Pędziwiatr M. A quest for sphincter-saving surgery in ultralow rectal tumours-a single-centre cohort study. World J Surg Oncol 2018;16:218. [PMID: 30404633 DOI: 10.1186/s12957-018-1513-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
188 Li A, He K, Guo D, Liu C, Wang D, Mu X, Yu J. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer. Future Oncol 2019;15:3233-42. [PMID: 31373223 DOI: 10.2217/fon-2019-0389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
189 Partl R, Magyar M, Hassler E, Langsenlehner T, Kapp KS. Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer. Radiat Oncol 2020;15:99. [PMID: 32375894 DOI: 10.1186/s13014-020-01554-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
190 Debove C, Guedj N, Tribillon E, Maggiori L, Zappa M, Panis Y. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response? Int J Colorectal Dis 2016;31:853-60. [DOI: 10.1007/s00384-016-2546-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
191 Nguyen P, Wuthrick E, Chablani P, Robinson A, Simmons L, Wu C, Arnold M, Harzman AE, Husain S, Schmidt C, Abdel-Misih S, Bekaii-Saab T, Chakravarti A, Williams TM. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. Am J Clin Oncol 2018;41:140-6. [PMID: 26535992 DOI: 10.1097/COC.0000000000000248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Zhan TC, Zhang DK, Gu J, Li M. Surgical complications after different therapeutic approaches for locally advanced rectal cancer. World J Gastrointest Oncol 2019; 11(5): 393-403 [PMID: 31139309 DOI: 10.4251/wjgo.v11.i5.393] [Reference Citation Analysis]
193 Colloca G, Venturino A, Vitucci P. Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis. Med Oncol 2017;34:177. [PMID: 28884291 DOI: 10.1007/s12032-017-1037-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
194 Bertocchi E, Barugola G, Nicosia L, Mazzola R, Ricchetti F, Dell'Abate P, Alongi F, Ruffo G. A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study. Radiol Med 2020;125:990-8. [PMID: 32277332 DOI: 10.1007/s11547-020-01189-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
195 Hoendervangers S, Burbach JPM, Lacle MM, Koopman M, van Grevenstein WMU, Intven MPW, Verkooijen HM. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2020;27:4319-36. [PMID: 32524461 DOI: 10.1245/s10434-020-08615-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
196 Chau A, Maggiori L, Debove C, Kanso F, Hennequin C, Panis Y. Toward the end of abdominoperineal resection for rectal cancer? An 8-year experience in 189 consecutive patients with low rectal cancer. Ann Surg. 2014;260:801-805; discussion 801-805. [PMID: 25243547 DOI: 10.1097/sla.0000000000000979] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
197 Dattani M, Heald RJ, Goussous G, Broadhurst J, São Julião GP, Habr-Gama A, Perez RO, Moran BJ. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis. Ann Surg 2018;268:955-67. [PMID: 29746338 DOI: 10.1097/SLA.0000000000002761] [Cited by in Crossref: 86] [Cited by in F6Publishing: 34] [Article Influence: 43.0] [Reference Citation Analysis]
198 Chapman BC, Goodman K, Hosokawa P, Gleisner A, Cowan ML, Birnbaum E, Vogel JD. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB: CHAPMAN et al.. J Surg Oncol 2019;119:518-31. [DOI: 10.1002/jso.25355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
199 Shin YS, Park JH, Yoon SM, Kim JC, Yu CS, Lim SB, Park IJ, Kim TW, Hong YS, Kim KP, Choi EK, Ahn SD, Lee SW, Kim JH. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis. Int J Radiat Oncol Biol Phys 2018;101:630-9. [PMID: 29678529 DOI: 10.1016/j.ijrobp.2018.02.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
200 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
201 Allaix ME, Fichera A. Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery. Ann Surg Oncol. 2013;20:2921-2928. [PMID: 23604783 DOI: 10.1245/s10434-013-2966-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
202 Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:501-513. [PMID: 28479372 DOI: 10.1016/s2468-1253(17)30074-2] [Cited by in Crossref: 187] [Cited by in F6Publishing: 74] [Article Influence: 46.8] [Reference Citation Analysis]
203 Zhang H, Jiang H, Chen L, Liu J, Hu X, Zhang H. Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells. Eur J Pharmacol 2018;818:364-70. [PMID: 29126793 DOI: 10.1016/j.ejphar.2017.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
204 Adamina M, Gié O, Demartines N, Ris F. Contemporary perioperative care strategies. British Journal of Surgery 2013;100:38-54. [DOI: 10.1002/bjs.8990] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
205 Baltussen EJM, Brouwer de Koning SG, Sanders J, Aalbers AGJ, Kok NFM, Beets GL, Hendriks BHW, Sterenborg HJCM, Kuhlmann KFD, Ruers TJM. Using Diffuse Reflectance Spectroscopy to Distinguish Tumor Tissue From Fibrosis in Rectal Cancer Patients as a Guide to Surgery. Lasers Surg Med 2020;52:604-11. [PMID: 31793012 DOI: 10.1002/lsm.23196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, Ghidini M, Turati L. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes. Ann Surg. 2020;271:440-448. [PMID: 31318794 DOI: 10.1097/sla.0000000000003471] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 56.0] [Reference Citation Analysis]
207 Palacios-Fuenmayor LJ, Naranjo-Isaza AM, Serna-Ortiz CA, Mosquera-Castro DA, Arbeláez-Leon LM, Gómez-Wolff LR, García-García HI, Sánchez-Patiño LA. Evaluation of the pathologic response to neoadjuvant treatment in rectal cancer. Experience at the Instituto de Cancerología de Medellín (Colombia, 2011-2017). Rev Gastroenterol Mex (Engl Ed) 2021;86:13-20. [PMID: 32173132 DOI: 10.1016/j.rgmx.2019.11.006] [Reference Citation Analysis]
208 Santos MD, Silva C, Rocha A, Nogueira C, Castro-Poças F, Araujo A, Matos E, Pereira C, Medeiros R, Lopes C. Predictive clinical model of tumor response after chemoradiation in rectal cancer. Oncotarget 2017;8:58133-51. [PMID: 28938543 DOI: 10.18632/oncotarget.19651] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
209 Glynne-jones R, Hughes R. Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code? Clinical Oncology 2016;28:152-60. [DOI: 10.1016/j.clon.2015.10.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
210 Gilshtein H, Duek S, Khoury W. Transanal Endoscopic Microsurgery: Current and Future Perspectives. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2016;26:e46-9. [DOI: 10.1097/sle.0000000000000273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
211 Ciga Lozano MÁ, Codina Cazador A, Ortiz Hurtado H. Resultados oncológicos según el tipo de resección en el tratamiento del cáncer de recto. Cirugía Española 2015;93:229-35. [DOI: 10.1016/j.ciresp.2014.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
212 Rose BS, Winer EP, Mamon HJ. Perils of the Pathologic Complete Response. J Clin Oncol 2016;34:3959-62. [PMID: 27551115 DOI: 10.1200/JCO.2016.68.1718] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 4.6] [Reference Citation Analysis]
213 Ryan ÉJ, O'Sullivan DP, Kelly ME, Syed AZ, Neary PC, O'Connell PR, Kavanagh DO, Winter DC, O'Riordan JM. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer. Br J Surg 2019;106:1298-310. [PMID: 31216064 DOI: 10.1002/bjs.11220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
214 Bertocchi E, Barugola G, Nicosia L, Mazzola R, Ricchetti F, Dell’abate P, Alongi F, Ruffo G. A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study. Radiol med 2020;125:990-8. [DOI: 10.1007/s11547-020-01189-9] [Reference Citation Analysis]
215 Lee TG, Son SM, Kim MJ, Lee SJ. Penile metastasis in rectal cancer with pathologic complete response after neoadjuvant chemoradiotherapy: The first case report and literature review. Medicine (Baltimore) 2020;99:e21215. [PMID: 32702890 DOI: 10.1097/MD.0000000000021215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Yildirim E, Bektas S, Pelen Z, Yanik I, Er AM, Cengel F, Gumuskaya PÖ. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. J Gastrointest Cancer 2021. [PMID: 34472012 DOI: 10.1007/s12029-021-00697-9] [Reference Citation Analysis]
217 Kennedy ED, Borowiec AM, Schmocker S, Cho C, Brierley J, Li S, Victor JC, Baxter NN. Patient and Physician Preferences for Nonoperative Management for Low Rectal Cancer: Is It a Reasonable Treatment Option? Dis Colon Rectum 2018;61:1281-9. [PMID: 30239397 DOI: 10.1097/DCR.0000000000001166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
218 Sinukumar S, Patil P, Engineer R, Desouza A, Saklani A. Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario. Gastroenterol Res Pract 2014;2014:867841. [PMID: 25610460 DOI: 10.1155/2014/867841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
219 Kim CA, Ahmed S, Ahmed S, Brunet B, Chalchal H, Deobald R, Doll C, Dupre MP, Gordon V, Lee-Ying RM, Lim H, Liu D, Loree JM, McGhie JP, Mulder K, Park J, Yip B, Wong RP, Zaidi A; Western Canadian Gastrointestinal Cancer Group. Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017. Curr Oncol 2018;25:275-84. [PMID: 30111968 DOI: 10.3747/co.25.4109] [Reference Citation Analysis]
220 Cusumano D, Meijer G, Lenkowicz J, Chiloiro G, Boldrini L, Masciocchi C, Dinapoli N, Gatta R, Casà C, Damiani A, Barbaro B, Gambacorta MA, Azario L, De Spirito M, Intven M, Valentini V. A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer. Radiol Med 2021;126:421-9. [PMID: 32833198 DOI: 10.1007/s11547-020-01266-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
221 Hsu YC, Luo CW, Huang WL, Wu CC, Chou CL, Chen CI, Chang SJ, Chai CY, Wang HC, Chen TY, Li CF, Pan MR. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Radiother Oncol 2020;149:249-58. [PMID: 32592893 DOI: 10.1016/j.radonc.2020.06.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
222 Park J, Chang KJ, Seo YS, Byun BH, Choi JH, Moon H, Lim I, Kim BI, Choi CW, Lim SM. Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Nucl Med Mol Imaging 2014;48:295-302. [PMID: 26396634 DOI: 10.1007/s13139-014-0289-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
223 Pucciarelli S, De Paoli A, Guerrieri M, La Torre G, Maretto I, De Marchi F, Mantello G, Gambacorta MA, Canzonieri V, Nitti D. Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum. 2013;56:1349-1356. [PMID: 24201388 DOI: 10.1097/dcr.0b013e3182a2303e] [Cited by in Crossref: 123] [Cited by in F6Publishing: 35] [Article Influence: 17.6] [Reference Citation Analysis]
224 Svoboda M, Sana J, Fabian P, Kocakova I, Gombosova J, Nekvindova J, Radova L, Vyzula R, Slaby O. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Radiat Oncol. 2012;7:195. [PMID: 23167930 DOI: 10.1186/1748-717x-7-195] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 8.7] [Reference Citation Analysis]
225 Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, Alfieri S, D'Ugo D, Persiani R, Deodato F, Crucitti A, Lupattelli M, Mantello G, Navarria F, Belluco C, Buonadonna A, Boso C, Lonardi S, Caravatta L, Barba MC, Vecchio FM, Maranzano E, Genovesi D, Doglietto GB, Morganti AG, La Torre G, Pucciarelli S, De Paoli A. The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer. Radiother Oncol 2019;134:110-8. [PMID: 31005204 DOI: 10.1016/j.radonc.2018.11.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
226 Hearn N, Atwell D, Cahill K, Elks J, Vignarajah D, Lagopoulos J, Min M. Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes. Clin Oncol (R Coll Radiol) 2021;33:e1-e14. [PMID: 32669228 DOI: 10.1016/j.clon.2020.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Verseveld M, de Graaf EJ, Verhoef C, van Meerten E, Punt CJ, de Hingh IH, Nagtegaal ID, Nuyttens JJ, Marijnen CA, de Wilt JH. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg. 2015;102:853-860. [PMID: 25847025 DOI: 10.1002/bjs.9809] [Cited by in Crossref: 114] [Cited by in F6Publishing: 87] [Article Influence: 19.0] [Reference Citation Analysis]
228 Walker BS, Sutton TL, Zarour L, Hunter JG, Wood SG, Tsikitis VL, Herzig DO, Lopez CD, Chen EY, Mayo SC, Wong MH. Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers. Ann Surg Oncol 2021. [PMID: 34365557 DOI: 10.1245/s10434-021-10379-2] [Reference Citation Analysis]
229 Shin YS, Yoon YS, Lim SB, Yu CS, Kim TW, Chang HM, Park JH, Ahn SD, Lee SW, Choi EK, Kim JC, Kim JH. Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer. Radiat Oncol J 2016;34:177-85. [PMID: 27730804 DOI: 10.3857/roj.2016.01872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
230 Sanoff HK, Moon DH, Moore DT, Boles J, Bui C, Blackstock W, O'Neil BH, Subramaniam S, McRee AJ, Carlson C, Lee MS, Tepper JE, Wang AZ. Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomedicine 2019;18:189-95. [PMID: 30858085 DOI: 10.1016/j.nano.2019.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
231 Chang GJ. Rectal Cancer: Watch and Wait. In: Steele SR, Hull TL, Read TE, Saclarides TJ, Senagore AJ, Whitlow CB, editors. The ASCRS Textbook of Colon and Rectal Surgery. Cham: Springer International Publishing; 2016. pp. 507-15. [DOI: 10.1007/978-3-319-25970-3_30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
232 Bogner A, Kirchberg J, Weitz J, Fritzmann J. State of the Art - Rectal Cancer Surgery. Visc Med. 2019;35:252-258. [PMID: 31602388 DOI: 10.1159/000501133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Hatt M, van Stiphout R, le Pogam A, Lammering G, Visvikis D, Lambin P. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET. Acta Oncol 2013;52:619-26. [PMID: 22873767 DOI: 10.3109/0284186X.2012.702923] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
234 Santos MD, Gomes MT, Moreno F, Rocha A, Lopes C. 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response. Case Rep Surg 2015;2015:816491. [PMID: 26579325 DOI: 10.1155/2015/816491] [Reference Citation Analysis]
235 Li LH, Chen ZF, Wang XF, Zhuo SM, Li HS, Jiang WZ, Guan GX, Chen JX. Multiphoton microscopy for tumor regression grading after neoadjuvant treatment for colorectal carcinoma. World J Gastroenterol 2015; 21(14): 4210-4215 [PMID: 25892870 DOI: 10.3748/wjg.v21.i14.4210] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
236 Bashir Y, Conlon KC. Step by step guide to do a systematic review and meta-analysis for medical professionals. Ir J Med Sci 2018;187:447-52. [PMID: 28735501 DOI: 10.1007/s11845-017-1663-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
237 Ryan ÉJ, Creavin B, Sheahan K. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm. Front Oncol 2020;10:1369. [PMID: 32923389 DOI: 10.3389/fonc.2020.01369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
238 Souadka A, Majbar MA, Raiss M. Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma? J Surg Oncol 2016;114:649. [PMID: 27709622 DOI: 10.1002/jso.24394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
239 Chan J, Kinsella MT, Willis JE, Hu H, Reynolds H Jr, Delaney C, McCulla A, Deharo S, Ahdesmäki M, Allen WL, Johnston PG, Kinsella TJ. A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer. Front Oncol 2013;3:288. [PMID: 24324931 DOI: 10.3389/fonc.2013.00288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
240 Melotti G, De Antoni E, Habr-Gama A, Minicozzi A. Management of distal rectal cancer: results from a national survey. Updates Surg 2013;65:43-52. [PMID: 23335049 DOI: 10.1007/s13304-012-0192-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
241 Vermeer TA, Kusters M, Rutten HJ. T4 rectal cancer: do we always need an exenteration? Recent Results Cancer Res. 2014;203:69-94. [PMID: 25103001 DOI: 10.1007/978-3-319-08060-4_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
242 Kim S, Chang S. Volumetric Parameters Changes of Sequential 18F-FDG PET/CT for Early Prediction of Recurrence and Death in Patients With Locally Advanced Rectal Cancer Treated With Preoperative Chemoradiotherapy. Clinical Nuclear Medicine 2015;40:930-5. [DOI: 10.1097/rlu.0000000000000917] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
243 Rao C, Sun Myint A, Athanasiou T, Faiz O, Martin AP, Collins B, Smith FM. Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective. Dis Colon Rectum 2017;60:30-42. [PMID: 27926555 DOI: 10.1097/DCR.0000000000000708] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
244 Gash K, Baser O, Kiran R. Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes. European Journal of Surgical Oncology 2017;43:2052-9. [DOI: 10.1016/j.ejso.2017.07.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
245 Creavin B, Kelly ME, Ryan E, Winter DC. Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. Br J Surg 2017;104:1609-19. [PMID: 29044484 DOI: 10.1002/bjs.10664] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
246 Ma W, Yu J, Qi X, Liang L, Zhang Y, Ding Y, Lin X, Li G, Ding Y. Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget. 2015;6:15984-15994. [PMID: 25961730 DOI: 10.18632/oncotarget.3762] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
247 Palmarocchi MC, Balzarotti Canger RC, Saletti P. Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report. Oncol Lett 2017;13:4445-52. [PMID: 28588713 DOI: 10.3892/ol.2017.6026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 van de Velde CJ, Boelens PG, Borras JM, Coebergh J, Cervantes A, Blomqvist L, Beets-tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. European Journal of Cancer 2014;50:1.e1-1.e34. [DOI: 10.1016/j.ejca.2013.06.048] [Cited by in Crossref: 228] [Cited by in F6Publishing: 218] [Article Influence: 32.6] [Reference Citation Analysis]
249 Recio-Boiles A, Hammad H, Howell K, Kalb BT, Nfonsam VN, Scott AJ, Babiker HM, Elquza E. Locally Advanced Rectal Cancer Evaluation by Magnetic Resonance Imaging after Neoadjuvant Therapy on Decision Making: Cancer Center Experience and Literature Review. J Gastrointest Cancer 2020;51:254-9. [PMID: 31054106 DOI: 10.1007/s12029-019-00246-5] [Reference Citation Analysis]
250 Buckley H, Wilson C, Ajithkumar T. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys 2017;99:111-27. [PMID: 28816137 DOI: 10.1016/j.ijrobp.2017.05.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
251 Sawada R, Akiyoshi T, Kitagawa Y, Hiyoshi Y, Mukai T, Nagasaki T, Yamaguchi T, Konishi T, Yamamoto N, Ueno M, Fukunaga Y. Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Ann Surg Oncol 2021. [PMID: 33876358 DOI: 10.1245/s10434-021-09975-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
252 Kye BH, Kim HJ, Kim G, Kim JG, Cho HM. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients. Cancer Res Treat 2016;48:561-6. [PMID: 26323642 DOI: 10.4143/crt.2015.114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
253 Akgun E, Caliskan C, Bozbiyik O, Yoldas T, Sezak M, Ozkok S, Kose T, Karabulut B, Harman M, Ozutemiz O. Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2018;105:1417-1425. [PMID: 30155949 DOI: 10.1002/bjs.10984] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
254 Chao X, Wang Z, Lu S, Huang Y, Zang S, Ding P, Zhang H, Yun J. Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer. Int J Clin Oncol 2020;25:1653-62. [PMID: 32556841 DOI: 10.1007/s10147-020-01697-8] [Reference Citation Analysis]
255 Wang Y, Yang L, Bao H, Fan X, Xia F, Wan J, Shen L, Guan Y, Bao H, Wu X, Xu Y, Shao Y, Sun Y, Tong T, Li X, Xu Y, Cai S, Zhu J, Zhang Z. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. PLoS Med 2021;18:e1003741. [PMID: 34464382 DOI: 10.1371/journal.pmed.1003741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
256 Wasmuth HH, Rekstad LC, Tranø G. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study. Colorectal Dis. 2015; Jul 22. [Epub ahead of print]. [PMID: 26201935 DOI: 10.1111/codi.13072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
257 Jia X, Xie P, Bi L, Meng X, Wang Z, Hong N, Wang Y. MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone. Br J Radiol 2021;94:20201221. [PMID: 33591799 DOI: 10.1259/bjr.20201221] [Reference Citation Analysis]
258 Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Tumor regression grades: can they influence rectal cancer therapy decision tree? Int J Surg Oncol. 2013;2013:572149. [PMID: 24187617 DOI: 10.1155/2013/572149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
259 Wee IJY, Cao HM, Ngu JC. The risk of nodal disease in patients with pathological complete responses after neoadjuvant chemoradiation for rectal cancer: a systematic review, meta-analysis, and meta-regression. Int J Colorectal Dis 2019;34:1349-57. [PMID: 31273449 DOI: 10.1007/s00384-019-03327-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
260 Probst CP, Becerra AZ, Aquina CT, Tejani MA, Hensley BJ, González MG, Noyes K, Monson JR, Fleming FJ. Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer. J Gastrointest Surg 2016;20:43-52; discussion 52. [PMID: 26546119 DOI: 10.1007/s11605-015-2987-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
261 Boldrini L, Cusumano D, Chiloiro G, Casà C, Masciocchi C, Lenkowicz J, Cellini F, Dinapoli N, Azario L, Teodoli S, Gambacorta MA, De Spirito M, Valentini V. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach. Radiol Med 2019;124:145-53. [PMID: 30374650 DOI: 10.1007/s11547-018-0951-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
262 Sakin A, Sahin S, Karyagar SS, Karyagar S, Atci M, Akboru MH, Cihan S. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. J Gastrointest Cancer 2021. [PMID: 33651265 DOI: 10.1007/s12029-021-00608-y] [Reference Citation Analysis]
263 Macchia G, Gambacorta MA, Masciocchi C, Chiloiro G, Mantello G, di Benedetto M, Lupattelli M, Palazzari E, Belgioia L, Bacigalupo A, Sainato A, Montrone S, Turri L, Caroli A, De Paoli A, Matrone F, Capirci C, Montesi G, Niespolo RM, Osti MF, Caravatta L, Galardi A, Genovesi D, Rosetto ME, Boso C, Sciacero P, Giaccherini L, Parisi S, Fontana A, Filippone FR, Picardi V, Morganti AG, Valentini V. Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients. Clin Transl Radiat Oncol 2017;4:8-14. [PMID: 29594202 DOI: 10.1016/j.ctro.2017.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
264 Omejc M, Potisek M. Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy. Radiol Oncol 2018;52:30-5. [PMID: 29520203 DOI: 10.1515/raon-2017-0059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
265 Kong JC, Guerra GR, Pham T, Mitchell C, Lynch AC, Warrier SK, Ramsay RG, Heriot AG. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis. Dis Colon Rectum 2019;62:498-508. [PMID: 30844974 DOI: 10.1097/DCR.0000000000001332] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
266 Nagtegaal ID, West NP, van Krieken JH, Quirke P. Pathology is a necessary and informative tool in oncology clinical trials. J Pathol 2014;232:185-9. [PMID: 24037805 DOI: 10.1002/path.4261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
267 Petrelli F, Sgroi G, Sarti E, Barni S. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies. Ann Surg. 2016;263:458-464. [PMID: 24263329 DOI: 10.1097/sla.0000000000000368] [Cited by in Crossref: 134] [Cited by in F6Publishing: 75] [Article Influence: 26.8] [Reference Citation Analysis]
268 Radwan RW, Evans MD, Davies M, Harris DA, Beynon J, Hatcher O, Bose P, Lucas MG, Featherstone J, Khot U, Chandrasekaran TV, Carr ND, Gwynne S, Drew P, Phan MD. Pelvic exenteration for advanced malignancy in elderly patients. British Journal of Surgery 2016;103:e115-9. [DOI: 10.1002/bjs.10058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
269 Clifford RE, Govindarajah N, Bowden D, Sutton P, Glenn M, Darvish-Damavandi M, Buczacki S, McDermott U, Szulc Z, Ogretmen B, Parsons JL, Vimalachandran D. Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer. Cells 2020;9:E2693. [PMID: 33334013 DOI: 10.3390/cells9122693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Fanelli GN, Loupakis F, Smyth E, Scarpa M, Lonardi S, Pucciarelli S, Munari G, Rugge M, Valeri N, Fassan M. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis. Int J Surg Pathol 2019;27:816-35. [PMID: 31416371 DOI: 10.1177/1066896919869477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
271 Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, Temple LK, Nash GM, Paty PB. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg. 2012;256:965-972. [PMID: 23154394 DOI: 10.1097/sla.0b013e3182759f1c] [Cited by in Crossref: 237] [Cited by in F6Publishing: 91] [Article Influence: 29.6] [Reference Citation Analysis]
272 Sakin A, Sahin S, Sengul Samanci N, Yasar N, Demir C, Geredeli C, Erhan SS, Akboru MH, Cihan S. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy. J Oncol Pharm Pract 2020;26:1611-20. [PMID: 32046577 DOI: 10.1177/1078155219900944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Clifford R, Govindarajah N, Parsons JL, Gollins S, West NP, Vimalachandran D. Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. Br J Surg 2018;105:1553-72. [PMID: 30311641 DOI: 10.1002/bjs.10993] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
274 Wang X, Ghareeb WM, Lu X, Huang Y, Huang S, Chi P. Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer. J Cell Biochem 2019;120:10351-62. [PMID: 30565747 DOI: 10.1002/jcb.28319] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
275 Loftås P, Arbman G, Fomichov V, Hallböök O. Nodal involvement in luminal complete response after neoadjuvant treatment for rectal cancer. Eur J Surg Oncol 2016;42:801-7. [PMID: 27146960 DOI: 10.1016/j.ejso.2016.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
276 Stipa F, Picchio M, Burza A, Soricelli E, Vitelli CE. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer. Dis Colon Rectum 2014;57:1245-52. [PMID: 25285690 DOI: 10.1097/DCR.0000000000000221] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
277 Silva VSE, Abdallah EA, Flores BCT, Braun AC, Costa DJF, Ruano APC, Gasparini VA, Silva MLG, Mendes GG, Claro LCL, Calsavara VF, Aguiar Junior S, de Mello CAL, Chinen LTD. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer. Cells 2021;10:1539. [PMID: 34207124 DOI: 10.3390/cells10061539] [Reference Citation Analysis]
278 Franke AJ, Skelton WP 4th, George TJ, Iqbal A. A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer 2021;20:1-19. [PMID: 32863179 DOI: 10.1016/j.clcc.2020.07.009] [Reference Citation Analysis]
279 Shang Y, Wang L, Zhu Z, Gao W, Li D, Zhou Z, Chen L, Fu CG. Downregulation of miR-423-5p Contributes to the Radioresistance in Colorectal Cancer Cells. Front Oncol 2020;10:582239. [PMID: 33505907 DOI: 10.3389/fonc.2020.582239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
280 McKeown E, Nelson DW, Johnson EK, Maykel JA, Stojadinovic A, Nissan A, Avital I, Brücher BL, Steele SR. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer 2014;5:31-43. [PMID: 24396496 DOI: 10.7150/jca.7987] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
281 Kong JCH, Guerra GR, Millen RM, Roth S, Xu H, Neeson PJ, Darcy PK, Kershaw MH, Sampurno S, Malaterre J, Liu DSH, Pham TD, Narasimhan V, Wang M, Huang Y, Visvanathan K, Mccormick J, Lynch AC, Warrier S, Michael M, Desai J, Murray W, Mitchell C, Ngan S, Phillips WA, Heriot AG, Ramsay RG. Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. JCO Precision Oncology 2018. [DOI: 10.1200/po.18.00075] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
282 Stijns RCH, Tromp MR, Hugen N, de Wilt JHW. Advances in organ preserving strategies in rectal cancer patients. Eur J Surg Oncol. 2018;44:209-219. [PMID: 29275912 DOI: 10.1016/j.ejso.2017.11.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
283 Wilkins S, Haydon A, Porter I, Oliva K, Staples M, Carne P, Mcmurrick P, Bell S. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion. Diseases of the Colon & Rectum 2016;59:361-8. [DOI: 10.1097/dcr.0000000000000564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
284 Kawai K, Sunami E, Hata K, Tanaka T, Nishikawa T, Otani K, Sasaki K, Nozawa H. Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer. Clin Colorectal Cancer 2018;17:240-6. [PMID: 29934092 DOI: 10.1016/j.clcc.2018.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
285 Zhang W, Zhu Y, Zhou Y, Wang J, Jiang P, Xue L. miRNA-31 increases radiosensitivity through targeting STK40 in colorectal cancer cells. Asia Pac J Clin Oncol 2021. [PMID: 34170070 DOI: 10.1111/ajco.13602] [Reference Citation Analysis]
286 Dayde D, Gunther J, Hirayama Y, Weksberg DC, Boutin A, Parhy G, Aguilar-Bonavides C, Wang H, Katayama H, Abe Y, Do KA, Hara K, Kinoshita T, Komori K, Shimizu Y, Tajika M, Niwa Y, Wang YA, DePinho R, Hanash S, Krishnan S, Taguchi A. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer. Cancers (Basel) 2021;13:3642. [PMID: 34298853 DOI: 10.3390/cancers13143642] [Reference Citation Analysis]
287 Landi F, Espín E, Rodrigues V, Vallribera F, Martinez A, Charpy C, Brunetti F, Azoulay D, de'Angelis N. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy. Int J Colorectal Dis 2017;32:255-64. [PMID: 27757541 DOI: 10.1007/s00384-016-2685-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
288 Nierop P, Verseveld M, Galjart B, Rothbarth J, Nuyttens J, van Meerten E, Burger J, Grünhagen D, Verhoef C. The liver-first approach for locally advanced rectal cancer and synchronous liver metastases. European Journal of Surgical Oncology 2019;45:591-6. [DOI: 10.1016/j.ejso.2018.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
289 Battersby NJ, Moran B, Yu S, Tekkis P, Brown G. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy. Expert Rev Gastroenterol Hepatol 2014;8:703-19. [PMID: 24954622 DOI: 10.1586/17474124.2014.906898] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
290 Bozkaya Y, Özdemir NY, Erdem GU, Güner EK, Ürün Y, Demirci NS, Yazıcı O, Köstek O, Zengin N. Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer. Journal of Oncological Sciences 2018;4:5-10. [DOI: 10.1016/j.jons.2017.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
291 Ortiz H, Biondo S, Codina A, Ciga MÁ, Enríquez-Navascués J, Espín E, García-Granero E, Roig JV. [Hospital variation in anastomotic leakage after rectal cancer surgery in the Spanish Association of Surgeons project: The contribution of hospital volume]. Cir Esp 2016;94:213-20. [PMID: 26875478 DOI: 10.1016/j.ciresp.2015.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
292 Tan Y, Shao R, Li J, Huang H, Wang Y, Zhang M, Cao J, Zhang J, Bu J. PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production. Ann Transl Med 2020;8:126. [PMID: 32175419 DOI: 10.21037/atm.2020.02.37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Zaborowski A, Stakelum A, Winter DC. Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Br J Surg. 2019;106:979-987. [PMID: 31074508 DOI: 10.1002/bjs.11171] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
294 Jiang W, Li M, Tan J, Feng M, Zheng J, Chen D, Liu Z, Yan B, Wang G, Xu S, Xiao W, Gao Y, Zhuo S, Yan J. A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients. Ann Surg Oncol 2021. [PMID: 34148136 DOI: 10.1245/s10434-021-10218-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
295 Burbach JP, Verkooijen HM, Intven M, Kleijnen JP, Bosman ME, Raaymakers BW, van Grevenstein WM, Koopman M, Seravalli E, van Asselen B, Reerink O. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. Trials 2015;16:58. [PMID: 25888548 DOI: 10.1186/s13063-015-0586-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
296 Resende HM, Jacob LFP, Quinellato LV, Matos D, da Silva EM; Cochrane Colorectal Cancer Group. Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd008531.pub2] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
297 Sorenson E, Lambreton F, Yu JQ, Li T, Denlinger CS, Meyer JE, Sigurdson ER, Farma JM. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation. J Surg Res 2019;243:242-8. [PMID: 31229791 DOI: 10.1016/j.jss.2019.04.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
298 Sun W, Xu J, Hu W, Zhang Z, Shen W. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Colorectal Dis. 2013;15:e231-e238. [PMID: 23384167 DOI: 10.1111/codi.12165] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
299 Tchelebi LT, Romesser PB, Feuerlein S, Hoffe S, Latifi K, Felder S, Chuong MD. Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management. Cancer Control 2020;27:1073274820969449. [PMID: 33118384 DOI: 10.1177/1073274820969449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
300 Tominaga T, Nonaka T, Tabata K, Sawai T, Nagayasu T. A pathological complete response after neoadjuvant triplet chemotherapy for locally advanced transverse colon cancer. Int J Surg Case Rep 2020;72:127-32. [PMID: 32535526 DOI: 10.1016/j.ijscr.2020.05.077] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Maggiori L, Bretagnol F, Aslam MI, Guedj N, Zappa M, Ferron M, Panis Y. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision? Surgery. 2014;155:468-475. [PMID: 24439750 DOI: 10.1016/j.surg.2013.10.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
302 Geiser AJ, Al-khamis A, Patel S, Sugrue J, Borsuk DJ, Marecik S, Kochar K, Park JJ. Rectal Cancer Complete Response Outcomes in a Community-Based Hospital Comparable with Large Cancer Centers When Multidisciplinary Approach to Rectal Cancer is Used. The American Surgeon 2019;85:530-8. [DOI: 10.1177/000313481908500532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
303 Lichthardt S, Wagner J, Löb S, Matthes N, Kastner C, Anger F, Germer CT, Wiegering A. Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: analysis from the German StuDoQ|Rectalcarcinoma registry. BMC Cancer 2020;20:49. [PMID: 31959130 DOI: 10.1186/s12885-020-6538-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
304 Timsit M, Albiges L, Méjean A, Escudier B. Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives. Expert Review of Anticancer Therapy 2014;12:1559-69. [DOI: 10.1586/era.12.142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]